Rhenman & Partners Asset Management AB boosted its position in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 14.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 800,000 shares of the biopharmaceutical company’s stock after acquiring an additional 100,000 […]
Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 22,700,000 shares, a growth of 15.7% from the April 30th total of 19,620,000 shares. Based on an average daily volume of 2,070,000 shares, the days-to-cover ratio […]
StockNews.com lowered shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) from a buy rating to a hold rating in a research report report published on Tuesday morning. Other equities analysts have also issued research reports about the company. HC Wainwright reiterated a buy rating and set a $29.00 price objective on shares of Dynavax Technologies […]
Market OverviewThe Global Biodefense Market is poised for significant growth in the coming years. Valued at USD 15.7 billion in 2023, the market is projected to reach approximately USD 36.8 billion by 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.9% during the forecast period from 2024 to 2033.Th.
Dynavax to Present at Upcoming Investor Conferences marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.